BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way ...
The pharma leader is betting that streamlined services may be a shot in the arm for Americans seeking care with its ...
Pfizer shares are trading lower by 10% in November. President-elect Donald Trump last week announced his intention to nominate Robert F. Kennedy Jr. to lead the HHS.
Pfizer has found a successor for Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the company’s own ...
A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange ...
The Motley Fool on MSN3d
Is It Time to Sell Eli Lilly and Pfizer Stocks?Lilly and Pfizer stocks have sold off sharply in recent weeks. Both drugmakers have had some bad news that caused their ...
No financial details of the collaborations were released. However, Pfizer and Flagship committed $50 million each for the ...
Chris Boshoff will take over as Pfizer’s next chief scientific officer as of January 1, replacing Mikael Dolsten who led the ...
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback